Jove
Visualize
Contact Us

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Multi-omics Profiling Combined With Molecular Docking Reveals Immune-inflammatory Proteins As Potential Drug Targets In Colorectal Cancer.
  1. Home
  3. Multi-omics Profiling Combined With Molecular Docking Reveals Immune-inflammatory Proteins As Potential Drug Targets In Colorectal Cancer.

Related Experiment Video

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

45.0K

Multi-omics profiling combined with molecular docking reveals immune-inflammatory proteins as potential drug targets

Xiaoping Dong1, Kun Zhang2, Siwei Yi1

  • 1National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, China; Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha, 410081, China.

Biochemical and Biophysical Research Communications
|August 30, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study reveals key molecular changes in colorectal cancer (CRC) development, identifying immune-inflammatory pathways and metabolic shifts. AZ-628 shows potential for inhibiting CRC cell proliferation and migration.

Keywords:
Anti-CancerColorectal cancerCompoundMulti-omics

More Related Videos

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

13.9K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K

Related Experiment Videos

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

45.0K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

13.9K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Colorectal cancer (CRC) is a leading global malignancy.
  • Tumorigenesis involves complex genetic and epigenetic alterations.
  • Understanding the molecular landscape is crucial for effective treatment.

Purpose of the Study:

  • To analyze multi-omics data from CRC patients across different clinical stages.
  • To identify key molecular pathways and biomarkers involved in CRC progression.
  • To explore potential therapeutic targets and interventions.

Main Methods:

  • Comparative multi-omics analysis (genomics, transcriptomics, proteomics, metabolomics).
  • Bioinformatics approaches for data integration and pathway analysis.
  • In silico drug prediction, molecular docking, and in vitro validation.

Main Results:

  • Up-regulation of immune-inflammatory pathways and down-regulation of cell adhesion/muscular contraction markers.
  • Identification of AZ-628 as a potential inhibitor of CRC cell proliferation and migration.
  • Metabolomics revealed altered carbon and amino acid metabolism, notably proline metabolism.

Conclusions:

  • Integrated multi-omics data provide insights into CRC pathogenesis.
  • Tumor development involves immune regulation, cellular structure changes, and metabolic reprogramming.
  • Targeting identified pathways and molecules like AZ-628 may offer therapeutic strategies.